{"id":"https://openalex.org/W2999880920","doi":"https://doi.org/10.1016/s0923-7534(20)33888-6","title":"Phase I/II Dose-Finding Study of Crizotinib (CRIZ) in Combination with Erlotinib (E) in Patients (PTS) with Advanced Non-Small Cell Lung Cancer (NSCLC)","display_name":"Phase I/II Dose-Finding Study of Crizotinib (CRIZ) in Combination with Erlotinib (E) in Patients (PTS) with Advanced Non-Small Cell Lung Cancer (NSCLC)","publication_year":2012,"publication_date":"2012-09-01","ids":{"openalex":"https://openalex.org/W2999880920","doi":"https://doi.org/10.1016/s0923-7534(20)33888-6","mag":"2999880920"},"language":"en","primary_location":{"id":"doi:10.1016/s0923-7534(20)33888-6","doi":"https://doi.org/10.1016/s0923-7534(20)33888-6","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0923-7534(20)33888-6","pdf_url":"https://doi.org/10.1016/s0923-7534(20)33888-6","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/s0923-7534(20)33888-6","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087923582","display_name":"Sai\u2010Hong Ignatius Ou","orcid":"https://orcid.org/0000-0002-1764-4975","observed_orcids":["https://orcid.org/0000-0002-1764-4975"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4390039238","display_name":"UC Irvine Chao Family Comprehensive Cancer Center","ror":"https://ror.org/05gzqy922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S.I. Ou","raw_affiliation_strings":["Chao Family Comprehensive Cancer Center, University of California at Irvine, Orange, CA, UNITED STATES OF AMERICA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chao Family Comprehensive Cancer Center, University of California at Irvine, Orange, CA, UNITED STATES OF AMERICA","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068824818","display_name":"Ramaswamy Govindan","orcid":"https://orcid.org/0000-0002-6964-9612","observed_orcids":["https://orcid.org/0000-0002-6964-9612"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Govindan","raw_affiliation_strings":["Medical Oncology, Washington University School of Medicine, St. Louis, MO, UNITED STATES OF AMERICA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Washington University School of Medicine, St. Louis, MO, UNITED STATES OF AMERICA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063427877","display_name":"Keith D. Eaton","orcid":"https://orcid.org/0000-0001-5025-2001","observed_orcids":["https://orcid.org/0000-0001-5025-2001"]},"institutions":[{"id":"https://openalex.org/I1332479046","display_name":"Seattle Cancer Care Alliance","ror":"https://ror.org/03jq88n71","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1332479046"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Eaton","raw_affiliation_strings":["Thoracic/head and Neck Oncology, \u00d9niversity of Washington/Seattle Cancer care Alliance, Seattle, WA, UNITED STATES OF AMERICA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic/head and Neck Oncology, \u00d9niversity of Washington/Seattle Cancer care Alliance, Seattle, WA, UNITED STATES OF AMERICA","institution_ids":["https://openalex.org/I1332479046","https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008924495","display_name":"Athanassios E. Argiris","orcid":"https://orcid.org/0000-0003-4075-8812","observed_orcids":["https://orcid.org/0000-0003-4075-8812"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Argiris","raw_affiliation_strings":["Oncology, University of Texas Health Sciences Center, San Antonio, TX, UNITED STATES OF AMERICA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, University of Texas Health Sciences Center, San Antonio, TX, UNITED STATES OF AMERICA","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004712121","display_name":"Gregory A. Otterson","orcid":"https://orcid.org/0000-0001-9877-8512","observed_orcids":["https://orcid.org/0000-0001-9877-8512"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Otterson","raw_affiliation_strings":["Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States of America","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113784180","display_name":"Francisco Robert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. Robert","raw_affiliation_strings":["Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, UNITED STATES OF AMERICA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, UNITED STATES OF AMERICA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014161698","display_name":"Nicoletta M. Brega","orcid":"https://orcid.org/0000-0002-5091-4631","observed_orcids":["https://orcid.org/0000-0002-5091-4631"]},"institutions":[{"id":"https://openalex.org/I4210142120","display_name":"Pfizer (Italy)","ror":"https://ror.org/03htt2d69","country_code":"IT","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210142120"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"N. Brega","raw_affiliation_strings":["Oncology, Pfizer Italia, Milan, ITALY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Pfizer Italia, Milan, ITALY","institution_ids":["https://openalex.org/I4210142120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053411791","display_name":"Tiziana Usari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142120","display_name":"Pfizer (Italy)","ror":"https://ror.org/03htt2d69","country_code":"IT","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210142120"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"T. Usari","raw_affiliation_strings":["Oncology, Pfizer Italia, Milan, ITALY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Pfizer Italia, Milan, ITALY","institution_ids":["https://openalex.org/I4210142120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000548110","display_name":"Weiwei Tan","orcid":"https://orcid.org/0000-0001-8915-1152","observed_orcids":["https://orcid.org/0000-0001-8915-1152"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Tan","raw_affiliation_strings":["Oncology, Pfizer, San Diego, CA, UNITED STATES OF AMERICA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Pfizer, San Diego, CA, UNITED STATES OF AMERICA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022339242","display_name":"Martin E Gutierrez","orcid":"https://orcid.org/0000-0003-3156-3159","observed_orcids":["https://orcid.org/0000-0003-3156-3159"]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Gutierrez","raw_affiliation_strings":["John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, UNITED STATES OF AMERICA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, UNITED STATES OF AMERICA","institution_ids":["https://openalex.org/I1324520350"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":1.4846,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.84829044,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"23","issue":null,"first_page":"ix423","last_page":"ix423"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8809999823570251},{"id":"https://openalex.org/keywords/met-inhibition","display_name":"MET inhibition","score":0.4740000069141388},{"id":"https://openalex.org/keywords/egfr-inhibition","display_name":"EGFR inhibition","score":0.7829999923706055},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6729999780654907},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8169999718666077},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8240000009536743},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8650000095367432},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.7139999866485596},{"id":"https://openalex.org/keywords/c-met","display_name":"c-Met","score":0.5550000071525574},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.4659999907016754},{"id":"https://openalex.org/keywords/esophagitis","display_name":"esophagitis","score":0.9070000052452087},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.6650000214576721},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.5849999785423279},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.4959999918937683},{"id":"https://openalex.org/keywords/egfr-inhibitor-resistance","display_name":"EGFR inhibitor resistance","score":0.5109999775886536}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9657394289970398},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.9570508003234863},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.8990667462348938},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6779509782791138},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6397193670272827},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5819071531295776},{"id":"https://openalex.org/C2779177807","wikidata":"https://www.wikidata.org/wiki/Q3658562","display_name":"non-small cell lung cancer (NSCLC)","level":4,"score":0.4100642204284668},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1986035406589508},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.09229674935340881},{"id":"https://openalex.org/C81729549","wikidata":"https://www.wikidata.org/wiki/Q4649475","display_name":"A549 cell","level":3,"score":0.0},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0923-7534(20)33888-6","doi":"https://doi.org/10.1016/s0923-7534(20)33888-6","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0923-7534(20)33888-6","pdf_url":"https://doi.org/10.1016/s0923-7534(20)33888-6","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/s0923-7534(20)33888-6","doi":"https://doi.org/10.1016/s0923-7534(20)33888-6","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0923-7534(20)33888-6","pdf_url":"https://doi.org/10.1016/s0923-7534(20)33888-6","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3000499077","https://openalex.org/W2529337595","https://openalex.org/W2936211142","https://openalex.org/W2439107762","https://openalex.org/W2923893167","https://openalex.org/W2461787650","https://openalex.org/W2999016555","https://openalex.org/W2886177207","https://openalex.org/W4312180573","https://openalex.org/W2099440178"],"abstract_inverted_index":null,"counts_by_year":[{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2020-01-23T00:00:00"}